BiomX Inc (PHGE)
0.453
+0.07
(+19.27%)
USD |
NYAM |
Apr 30, 16:00
0.453
0.00 (0.00%)
After-Hours: 20:00
BiomX Free Cash Flow (Quarterly): -6.249M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -6.249M |
September 30, 2023 | -5.954M |
June 30, 2023 | -4.078M |
March 31, 2023 | -5.055M |
December 31, 2022 | -7.20M |
September 30, 2022 | -5.482M |
June 30, 2022 | -9.139M |
March 31, 2022 | -7.383M |
December 31, 2021 | -9.193M |
September 30, 2021 | -6.995M |
June 30, 2021 | -7.237M |
Date | Value |
---|---|
March 31, 2021 | -7.83M |
December 31, 2020 | -7.469M |
September 30, 2020 | -6.111M |
June 30, 2020 | -4.746M |
March 31, 2020 | -7.13M |
September 30, 2019 | -0.2699M |
June 30, 2019 | -0.1025M |
March 31, 2019 | -0.0261M |
December 31, 2018 | -0.0753M |
September 30, 2018 | -0.0006M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.193M
Minimum
Dec 2021
-0.1025M
Maximum
Jun 2019
-5.979M
Average
-6.622M
Median
Free Cash Flow (Quarterly) Benchmarks
Taro Pharmaceutical Industries Ltd | -3.553M |
InspireMD Inc | -4.392M |
Alpha Tau Medical Ltd | -- |
Pluri Inc | -3.77M |
Raphael Pharmaceutical Inc | -0.088M |